Jacques; Yannick

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jacques; Yannick.The latest application filed is for "il-15ralpha sushi domain - il-15 fusion proteins".

Company Profile

6.9.10

Jacques; Yannick - Nantes FR
Jacques; Yannick - Nantes Cedex FR
Jacques; Yannick - Nantes Cedex 01 FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uses of IL-15 antagonists for the treatment of autoimmune and inflammatory diseases Grant 11,008,374 - Jacques , et al. May 18, 2	2021-05-18
Specific interleukin-15 (IL-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases Grant 10,858,452 - Mortier , et al. December 8, 2	2020-12-08
Il-15ralpha Sushi Domain - Il-15 Fusion Proteins App 20200109184 - Jacques; Yannick ; et al.	2020-04-09
IL-15Ralpha sushi domain--IL-15 fusion proteins Grant 10,358,477 - Jacques , et al. July 23, 2	2019-07-23
Interleukin 15 (IL-15) Antagonists and Uses Thereof for the Treatment of Autoimmune Diseases and Inflammatory Diseases App 20190106472 - Jacques; Yannick ; et al.	2019-04-11
IL-15 mutant polypeptides as IL-15 antagonists and encoding nucleic acids Grant 10,202,433 - Jacques , et al. Feb	2019-02-12
Specific Interleukin-15 (il-15) Antagonist Polypeptide And Uses Thereof For The Treatment Of Inflammatory And Auto-immune Diseases App 20180258174 - MORTIER; Erwan ; et al.	2018-09-13
Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients Grant 9,915,662 - Bigot-Corbel , et al. March 13, 2	2018-03-13
IL-15 mutants having antagonist activity Grant 9,493,533 - Bernard , et al. November 15, 2	2016-11-15
Interleukin 15 (IL-15) Antagonists and Uses Thereof for the Treatment of Autoimmune Diseases and Inflammatory Diseases App 20160130318 - Jacques; Yannick ; et al.	2016-05-12
Protein Microarray For Characterizing The Specificity Of The Monoclonal Immunoglobulins Of Mgus Or Myeloma Patients App 20150204876 - Bigot-Corbel; Edith ; et al.	2015-07-23
Method for Predicting the Responsiveness to an Anti-TNF Alpha Antibody Treatment App 20120058110 - Jacques; Yannick	2012-03-08
Il-15 Binding Site For Il 15-ralpha And Specific Il-15 Mutants Having Agonists / Antagonists Activity App 20110158938 - Bernard; Jerome ; et al.	2011-06-30
IL-15 mutants having agonists/antagonists activity Grant 7,858,081 - Bernard , et al. December 28, 2	2010-12-28
Il-15ralpha Sushi Domain As A Selective And Potent Enhancer Of Il-15 Action Through Il-15beta/gamma, And Hyperagonist (il-15ralpha Sushi - Il-15) Fusion Proteins App 20090238791 - Jacques; Yannick ; et al.	2009-09-24
Il-15 Binding Site for Il 15-Ralpha and Specific Il-15 Mutants Having Agonists/Antagonists Activity App 20080255039 - Bernard; Jerome ; et al.	2008-10-16
Il-11 muteins App 20070190024 - Paris; Francois Emmanuel ; et al.	2007-08-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.